An open-label, phase IV randomised controlled trial of two schedules of a four-component meningococcal B vaccine in UK preterm infants

Objective: To compare immunological responses of preterm infants to a four-component meningococcal B vaccine (4CMenB; Bexsero) following a 2+1 vs a 3+1 schedule, and to describe reactogenicity of routine vaccines. Design: An open-label, phase IV randomised study conducted across six UK sites. Settin...

Full description

Bibliographic Details
Main Authors:	Calvert, A, Andrews, N, Barlow, S, Borrow, R, Black, C, Bromage, B, Carr, J, Clarke, P, Collinson, AC, Few, K, Hayward, N, Jones, CE, Le Doare, K, Ladhani, SN, Louth, J, Papadopoulou, G, Pople, M, Scorrer, T, Snape, MD, Heath, PT
Format:	Journal article
Language:	English
Published:	BMJ Publishing Group 2024

An open-label, phase IV randomised controlled trial of two schedules of a four-component meningococcal B vaccine in UK preterm infants

Similar Items